Jagsonpal Pharmaceuticals Limited, a leading company operating in women healthcare segment announced the launch of QueeZy-ER providing relief from Nausea and Vomiting in Pregnancy (NVP).

The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation.

The product comes with a tablet-intablet technology, which allows dispersal of uniform dosage at two different time-periods from the same dose, thereby allowing for 24-hour benefit to the patient. This allows for a single dose as against the conventional requirement of up to 3-4 tablets a day.

Further, the overall therapy cost per day is lower as compared to conventional pills.

The combination of Doxylamine succinate 20mg and Pyridoxine hydrochloride 20mg is the only USFDA approved combination for NVP treatment.